Risk factors for primary open-angle glaucoma in subjects with ocular hypertension

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"For the cases: - Male or female aged 40 years or older; - Patients with a diagnosed POAG, confirmed by a structural and function degradation; - Patients for whom a IOP > 21 mm Hg was recorded at one time in the evolution of the disease. For the controls - Male or female paired with the age of the case (± 2 years); - Patients having an IOP > 21 mm Hg on the day of the examination and/or a hypotonisant treatment; - Patients with a visual acuity with optimal correction higher than 5/10; - Patients with no anomaly in the visual field characteristic of glaucoma.","clusion_E":""}